Wall Drugs offered an incentive stock option plan to its employees. On January 1, 2021, options were granted for 69,000 $1 par common shares. The exercise price equals the $3 market price of the common stock on the grant date. The options cannot be exercised before January 1, 2024, and expire December 31, 2025. Each option has a fair value of $1 based on an option pricing model. Which is the correct entry to record compensation expense for the year 2021?

\begin{tabular}{|c|l|l|} \hline Compensation expense & 23,000 & \\ \hline Paid-in capital-stock options & & 23,000 \\ \hline \end{tabular} \begin{tabular}{|c|l|l|} \hline Compensation expense & 92,000 & \\ \hline Paid-in capital-stock options & & 92,000 \\ \hline \end{tabular} \begin{tabular}{|c|c|c|} \hline Compensation expense & 13,800 & \\ \hline Paid-in capital-stock options & & 13,800 \\ \hline \end{tabular} \begin{tabular}{|c|l|l|} \hline Compensation expense & 23,000 & \\ \hline Common stock & & 23,000 \\ \hline \end{tabular}